Παρακολούθηση
Martin Law
Martin Law
Medical Research Council Biostatistics Unit, Cambridge, UK
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα mrc-bsu.cam.ac.uk - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
A comparison of seven random‐effects models for meta‐analyses that estimate the summary odds ratio
D Jackson, M Law, T Stijnen, W Viechtbauer, IR White
Statistics in medicine 37 (7), 1059-1085, 2018
1712018
Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease
GC Donaldson, M Law, B Kowlessar, R Singh, SE Brill, JP Allinson, ...
American journal of respiratory and critical care medicine 192 (8), 943-950, 2015
1502015
The Hartung‐Knapp modification for random‐effects meta‐analysis: A useful refinement but are there any residual concerns?
D Jackson, M Law, G Rücker, G Schwarzer
Statistics in medicine 36 (25), 3923-3934, 2017
1272017
Some recommendations for multi-arm multi-stage trials
J Wason, D Magirr, M Law, T Jaki
Statistical methods in medical research 25 (2), 716-727, 2016
1052016
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
SE Brill, M Law, E El-Emir, JP Allinson, P James, V Maddox, ...
Thorax 70 (10), 930-938, 2015
812015
Two new methods to fit models for network meta-analysis with random inconsistency effects
M Law, D Jackson, R Turner, K Rhodes, W Viechtbauer
BMC Medical Research Methodology 16 (87), 2016
522016
Editor's choice–the implications of non-compliance to endovascular aneurysm repair surveillance: a systematic review and meta-analysis
MJ Grima, M Boufi, M Law, D Jackson, K Stenson, B Patterson, I Loftus, ...
European Journal of Vascular and Endovascular Surgery 55 (4), 492-502, 2018
502018
Extending DerSimonian and Laird's methodology to perform network meta‐analyses with random inconsistency effects
D Jackson, M Law, JK Barrett, R Turner, JPT Higgins, G Salanti, IR White
Statistics in medicine 35 (6), 819-839, 2016
392016
A matrix‐based method of moments for fitting multivariate network meta‐analysis models with multiple outcomes and random inconsistency effects
D Jackson, S Bujkiewicz, M Law, RD Riley, IR White
Biometrics 74 (2), 548-556, 2018
342018
Paule‐Mandel estimators for network meta‐analysis with random inconsistency effects
D Jackson, AA Veroniki, M Law, AC Tricco, R Baker
Research synthesis methods 8 (4), 416-434, 2017
222017
Residual plots for linear regression models with censored outcome data: A refined method for visualizing residual uncertainty
M Law, D Jackson
Communications in Statistics-Simulation and Computation 46 (4), 3159-3171, 2017
192017
Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin. A double-blind, randomized, placebo-controlled …
AI Ritchie, SE Brill, BH Vlies, LJ Finney, JP Allinson, L Alves-Moreira, ...
American journal of respiratory and critical care medicine 202 (4), 549-557, 2020
82020
A stochastically curtailed single‐arm phase II trial design for binary outcomes
M Law, MJ Grayling, AP Mander
Journal of biopharmaceutical statistics 32 (5), 671-691, 2022
7*2022
Two new approaches for the visualisation of models for network meta-analysis
M Law, N Alam, AA Veroniki, Y Yu, D Jackson
BMC Medical Research Methodology 19, 1-18, 2019
72019
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy
MR Wilkins, MA Mckie, M Law, AA Roussakis, L Harbaum, C Church, ...
Pulmonary Circulation 11 (4), 20458940211052823, 2021
62021
A double-blind, randomized, placebo-controlled trial of long-term doxycycline therapy on exacerbation rate in patients with stable chronic obstructive pulmonary disease
JP Allinson, BH Vlies, SE Brill, M Law, G Burnside, LJ Finney, ...
American journal of respiratory and critical care medicine 208 (5), 549-558, 2023
52023
A stochastically curtailed two‐arm randomised phase II trial design for binary outcomes
M Law, MJ Grayling, AP Mander
Pharmaceutical statistics 20 (2), 212-228, 2021
42021
Misspecification of at-risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation
M Law, MJ Sweeting, G Donaldson, JA Wedzicha
Pharmaceutical Statistics, 2016
42016
Exact Likelihood Methods for Group-Based Summaries
T Stijnen, CH Schmid, M Law, D Jackson, IR White
Handbook of Meta-Analysis, 2020
32020
Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research …
M Law, DL Couturier, B Choodari-Oskooei, P Crout, C Gamble, P Jacko, ...
Trials 24 (1), 640, 2023
22023
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20